Page last updated: 2024-08-24

batanopride and Vomiting

batanopride has been researched along with Vomiting in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Osoba, D; Pater, J; Rusthoven, J; Slamet, L; Warr, D; Zee, B1
Findlay, B; Kaizer, L; Laberge, F; Latreille, J; Lofters, WS; Osoba, D; Pater, J; Rusthoven, J; Warr, D; Wilson, K1
Gandara, DR; Hesketh, PJ1
Fleming, GF; Francher, D; Janisch, L; McEvilly, JM; Smaldone, L; Vokes, EE1
King, GL1
Aapro, M; Alberts, D; Brady, M; Comerski, C; Dorn, M; Fairchild, C; Plezia, P; Sartiano, G; Schwartz, SE; Smaldone, L1
King, GL; Landauer, MR1
Buyniski, JP; Crenshaw, RR; Gylys, JA; Nicolosi, WD; Wright, RN1

Reviews

2 review(s) available for batanopride and Vomiting

ArticleYear
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting

1994
Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis.
    Cancer treatment reviews, 1990, Volume: 17, Issue:2-3

    Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dogs; Dopamine Antagonists; Female; Ferrets; Hemodynamics; Humans; Male; Metoclopramide; Mice; Middle Aged; Neoplasms; Rats; Serotonin Antagonists; Vomiting

1990

Trials

3 trial(s) available for batanopride and Vomiting

ArticleYear
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting

1994
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:9

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart; Humans; Hypotension; Life Tables; Male; Methylprednisolone; Metoclopramide; Multivariate Analysis; Serotonin Antagonists; Treatment Outcome; Vomiting

1991
Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:3

    Topics: Antiemetics; Cisplatin; Double-Blind Method; Drug Tolerance; Humans; Infusions, Intravenous; Metoclopramide; Time Factors; Vomiting

1991

Other Studies

4 other study(ies) available for batanopride and Vomiting

ArticleYear
Serotonin antagonists: a new class of antiemetic agents.
    Journal of the National Cancer Institute, 1991, May-01, Volume: 83, Issue:9

    Topics: Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Granisetron; Humans; Imidazoles; Indazoles; Indoles; Metoclopramide; Ondansetron; Quinolizines; Receptors, Serotonin; Serotonin Antagonists; Tropanes; Tropisetron; Vomiting

1991
Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:3

    Topics: Administration, Oral; Animals; Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Defecation; Dose-Response Relationship, Drug; Ferrets; Granisetron; Indazoles; Injections, Intravenous; Male; Metoclopramide; Pyrazoles; Serotonin; Serotonin Antagonists; Vagotomy; Vomiting

1990
Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:3

    Topics: Animals; Antiemetics; Behavior, Animal; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Dose-Response Relationship, Radiation; Ferrets; Gait; Injections, Intraperitoneal; Male; Metoclopramide; Radiation Injuries, Experimental; Vagotomy; Vomiting

1990
BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:3

    Topics: Animals; Antiemetics; Apomorphine; Cisplatin; Cyclophosphamide; Dogs; Doxorubicin; Female; Ferrets; Male; Metoclopramide; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Reflex; Vomiting

1988